Clinical Trial Update: Study Evaluating CCI-779 in Active Rheumatoid Arthritis on Concomitant Methotrexate Therapy [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating CCI-779 (temsirolimus) in active rheumatoid arthritis on methotrexate has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• CCI-779 (temsirolimus)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Rheumatoid Arthritis | Phase 2 | Status: TERMINATED